Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$417,688,338
+$125,312,771 QoQ
Shares Held
348,239
+9.6% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#171
of 4,632 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLP KAPITALFORVALTNING AS holds $1,482,232,865 across 11 Drug Manufacturers - General names. LLY ranks #1 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
348,239 | $417,688,338 | |
| 2 | JNJ |
Johnson & Johnson
|
1,174,114 | $298,189,732 | |
| 3 | ABBV |
AbbVie Inc.
|
836,672 | $210,540,142 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,277,070 | $164,103,495 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
762,308 | $96,309,992 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,643,058 | $94,673,001 | |
| 7 | AMGN |
Amgen Inc
|
226,396 | $81,982,519 | |
| 8 | PFE |
Pfizer Inc
|
3,111,232 | $74,918,466 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $417,688,338 | 348,239 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $292,375,567 | 317,879 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $331,301,306 | 308,279 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $232,500,597 | 304,719 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $236,991,931 | 304,019 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $242,833,232 | 294,019 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $223,045,468 | 288,919 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||